Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses

This publication has 88 references indexed in Scilit:

• Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
  Blood, 2002
• Primary melanoma tumour regression associated with an immune response to the tumour‐associated antigen melan‐A/MART‐1
  International Journal of Cancer, 2001
• T Cell Antigen Receptor Vaccines for Active Therapy of T Cell Malignancies
  Annals of the New York Academy of Sciences, 2001
• Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness
  International Journal of Cancer, 2001
• CancerVax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon Cancer
  Annals of Surgical Oncology, 2001
• A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death
  Current Biology, 2001
• Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases
  Cancer, 1999
• The cytokine microenvironment of human colon carcinoma: Lymphocyte expression of tumor necrosis factor-α and interleukin-4 predicts improved survival
  Cancer, 1996
• Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevance
  Immunology Today, 1995
• A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
  Science, 1986